Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors

Bioconjugate Chemistry

Volumn 23, Issue 6, 2012, Pages 1149-1156

  Qi, Shibo ^a,b   Miao, Zheng ^a   Liu, Hongguang ^a   Xu, Yingding ^a   Feng, Yaqing ^b   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TIANJIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BIOSYNTHESIS; CELLS; CYTOLOGY; DISEASES; FLOW CYTOMETRY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; INFRARED DEVICES; MAMMALS; MOLECULAR IMAGING; OPTICAL IMAGE STORAGE; PROTEINS; TUMORS;

AFFIBODY; BINDING AFFINITIES; EPIDERMAL GROWTH FACTOR RECEPTORS; FOUR-PROBE; IN-VIVO; MALEIMIDES; NEAR-INFRARED FLUORESCENT; NEAR-INFRARED FLUORESCENT DYES; NORMAL TISSUE; RECEPTOR-1;

PROBES;

ALEXA FLUOR 680 MALEIMIDE; CYSTEINE 5.5 MONOMALEIMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCENT DYE; IRDYE 800CW MALELIMIDE; SRFLUOR680 MALEIMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL STRAIN MCF 7; CLINICAL EVALUATION; CONJUGATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR PROBE; MOUSE; NEAR INFRARED FLUORESCENT PROBE; NONHUMAN; PROTEIN EXPRESSION; SOLID PHASE SYNTHESIS;

ANIMALS; CARBOCYANINES; CELL LINE, TUMOR; FEMALE; FLUORESCENT DYES; HUMANS; MICE; MICE, NUDE; MODELS, MOLECULAR; NEOPLASMS; OPTICAL IMAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS;

EID: 84862651310     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200596a     Document Type: Article

References (33)

1. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300.
2. Burris, H. A., 3rd. (2004) Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib. Oncologist 9 (Suppl 3), 10-5.
3. Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., Skarlos, D., Campone, M., Davidson, N., Berger, M., Oliva, C., Rubin, S. D., Stein, S., and Cameron, D. (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N. Engl. J. Med. 355, 2733-43.
4. Jones, H. E., Goddard, L., Gee, J. M., Hiscox, S., Rubini, M., Barrow, D., Knowlden, J. M., Williams, S., Wakeling, A. E., and Nicholson, R. I. (2004) Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocr. Relat. Cancer 11, 793-814.
5. Van Cutsem, E., Kohne, C. H., Hitre, E., Zaluski, J., Chang Chien, C. R., Makhson, A., D'Haens, G., Pinter, T., Lim, R., Bodoky, G., Roh, J. K., Folprecht, G., Ruff, P., Stroh, C., Tejpar, S., Schlichting, M., Nippgen, J., and Rougier, P. (2009) Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N. Engl. J. Med. 360, 1408-17.
6. Wang, H., Yu, J., Yang, G., Song, X., Sun, X., Zhao, S., and Mu, D. (2007) Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression. Cancer Sci. 98, 1413-6.
7. Su, H., Seimbille, Y., Ferl, G. Z., Bodenstein, C., Fueger, B., Kim, K. J., Hsu, Y. T., Dubinett, S. M., Phelps, M. E., Czernin, J., and Weber, W. A. (2008) Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. Eur. J. Nucl. Med. Mol. Imaging 35, 1089-99.
8. Hosse, R. J., Rothe, A., and Power, B. E. (2006) A new generation of protein display scaffolds for molecular recognition. Protein Sci. 15, 14-27.
9. Binz, H. K., Amstutz, P., and Pluckthun, A. (2005) Engineering novel binding proteins from nonimmunoglobulin domains. Nat. Biotechnol. 23, 1257-68.
10. Lofblom, J., Feldwisch, J., Tolmachev, V., Carlsson, J., Stahl, S., and Frejd, F. Y. (2010) Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett. 584, 2670-80.
11. Nilsson, F. Y., and Tolmachev, V. (2007) Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy. Curr. Opin. Drug Discovery Dev. 10, 167-75.
12. Tolmachev, V., Orlova, A., Nilsson, F. Y., Feldwisch, J., Wennborg, A., and Abrahmsen, L. (2007) Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy. Expert Opin. Biol. Ther. 7, 555-68.
13. Miao, Z., Levi, J., and Cheng, Z. (2010) Protein scaffold-based molecular probes for cancer molecular imaging. Amino Acids,.
14. Cheng, Z., De Jesus, O. P., Namavari, M., De, A., Levi, J., Webster, J. M., Zhang, R., Lee, B., Syud, F. A., and Gambhir, S. S. (2008) Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J. Nucl. Med. 49, 804-13.
15. Lee, S. B., Hassan, M., Fisher, R., Chertov, O., Chernomordik, V., Kramer-Marek, G., Gandjbakhche, A., and Capala, J. (2008) Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin. Cancer Res. 14, 3840-9.
16. Miao, Z., Levi, J., and Cheng, Z. (2011) Protein scaffold-based molecular probes for cancer molecular imaging. Amino Acids 41, 1037-47.
17. Lindborg, M., Cortez, E., Hoiden-Guthenberg, I., Gunneriusson, E., von Hage, E., Syud, F., Morrison, M., Abrahmsen, L., Herne, N., Pietras, K., and Frejd, F. Y. (2011) Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor beta in vivo. J. Mol. Biol. 407, 298-315.
18. Friedman, M., Orlova, A., Johansson, E., Eriksson, T. L., Hoiden-Guthenberg, I., Tolmachev, V., Nilsson, F. Y., and Stahl, S. (2008) Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. J. Mol. Biol. 376, 1388-402.
19. Miao, Z., Ren, G., Liu, H., Jiang, L., and Cheng, Z. (2010) Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein. Bioconjugate Chem. 21, 947-54.
20. Miao, Z., Ren, G., Liu, H., Jiang, L., and Cheng, Z. (2010) Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors. J. Biomed. Opt. 15, 036007.
21. Tolmachev, V., Orlova, A., Wei, Q., Bruskin, A., Carlsson, J., and Gedda, L. (2004) Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice. Cancer Biother. Radiopharm. 19, 491-501.
22. Johnson, J. R., Fu, N., Arunkumar, E., Leevy, W. M., Gammon, S. T., Piwnica-Worms, D., and Smith, B. D. (2007) Squaraine rotaxanes: superior substitutes for Cy-5 in molecular probes for near-infrared fluorescence cell imaging. Angew. Chem., Int. Ed. Engl. 46, 5528-31.
23. Arunkumar, E., Fu, N., and Smith, B. D. (2006) Squaraine-derived rotaxanes: highly stable, fluorescent near-IR dyes. Chemistry 12, 4684-90.
24. Arunkumar, E., Forbes, C. C., Noll, B. C., and Smith, B. D. (2005) Squaraine-derived rotaxanes: sterically protected fluorescent near-IR dyes. J. Am. Chem. Soc. 127, 3288-9.
25. Troy, T., Jekic-McMullen, D., Sambucetti, L., and Rice, B. (2004) Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol. Imaging 3, 9-23.
26. Cheng, Z., Wu, Y., Xiong, Z., Gambhir, S. S., and Chen, X. (2005) Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjugate Chem. 16, 1433-41.
27. Withrow, K. P., Newman, J. R., Skipper, J. B., Gleysteen, J. P., Magnuson, J. S., Zinn, K., and Rosenthal, E. L. (2008) Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technol. Cancer Res. Treat. 7, 61-6.
28. Wang, K., Li, W., Huang, T., Li, R., Wang, D., Shen, B., and Chen, X. (2009) Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Acta Radiol. 50, 1095-103.
29. Adams, K. E., Ke, S., Kwon, S., Liang, F., Fan, Z., Lu, Y., Hirschi, K., Mawad, M. E., Barry, M. A., and Sevick-Muraca, E. M. (2007) Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J. Biomed. Opt. 12, 024017.
30. Cuartero-Plaza, A., Martinez-Miralles, E., Rosell, R., Vadell-Nadal, C., Farre, M., and Real, F. X. (1996) Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor. Clin. Cancer Res. 2, 13-20.
31. Diagaradjane, P., Orenstein-Cardona, J. M., Colon-Casasnovas, N. E., Deorukhkar, A., Shentu, S., Kuno, N., Schwartz, D. L., Gelovani, J. G., and Krishnan, S. (2008) Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin. Cancer Res. 14, 731-41.
32. Lyakhov, I., Zielinski, R., Kuban, M., Kramer-Marek, G., Fisher, R., Chertov, O., Bindu, L., and Capala, J. (2010) HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging. ChemBioChem 11, 345-50.
33. Gong, H., Kovar, J., Little, G., Chen, H., and Olive, D. M. (2010) In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia 12, 139-49.